Sign Up to like & get
recommendations!
0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/srep43028
Abstract: Because of high mortality caused by cardiovascular diseases, various fibrinolytic agents with diverse pharmacokinetic and pharmacodynamic properties have been developed. A novel mutated chimeric tissue plasminogen activator (mt-PA) was developed by the removal of first…
read more here.
Keywords:
chimeric tissue;
plasminogen;
novel mutated;
plasminogen activator ... See more keywords